ArticleBiomedicines2022

Hydroxychloroquine on the Pulmonary Vascular Diseases in Interstitial Lung Disease: Immunologic Effects, and Virus Interplay.

Jun-Jun Yeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.